Skip to Navigation
North Cumbria Integrated Care NHS Foundation Trust
Specialist MDT: The Newcastle upon Tyne Hospitals NHS Foundation Trust
|
Diagnosing Trust
|
Specialist MDT
|
| No. of Cancer Registry records |
222 |
1200 |
|
Performance Status recorded
|
29% |
66% |
|
PSA completed
|
59% |
70% |
|
Gleason Score completed
|
84% |
85% |
|
TNM completed
|
77% |
83% |
|
Risk group assigned
|
95% |
98% |
|
Specialist MDT
|
National |
| No. of men with disease status determined |
1183 |
49027 |
|
Percentage of men diagnosed with metastatic disease
|
17% |
13% |
|
Specialist MDT
|
National |
|
No. of men diagnosed with low-risk localised disease
|
122 |
3055 |
|
Percentage of men with low-risk localised disease receiving radical treatment
|
0% |
5% |
|
No. of men diagnosed with locally advanced disease
|
509 |
19663 |
| Percentage of men diagnosed with locally advanced disease receiving radical treatment |
70% |
71% |
| No. of men diagnosed with M1 (metastases) |
199 |
6136 |
| Percentage of men diagnosed with M1 (metastases) receiving docetaxel |
30% |
36% |
|
Specialist MDT
|
National |
|
No. of men diagnosed 1st April 18 - 30th Sept 18 who had radical treatment (surgery or radiotherapy) and were sent a questionnaire
|
279 |
10750 |
| Percentage of men who responded |
81% |
78% |
|
|
No. of men who completed CNS question
|
218 |
8137 |
| Percentage of men who were ‘given the name of a CNS’ |
93% |
87% |
|
| No. of men who rated their overall care on a scale of 1-10 |
215 |
7878 |
| Percentage of men who rated their overall care as 8 or above |
94% |
91% |
|
Treatment Centre |
|
No. of men who received radical radiotherapy (2017)
|
56 |
|
Adjusted percentage of men
receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication)
(%)
|
2% |
|
Treatment Centre |
|
|
No. of men diagnosed 1st April 18 - 30th Sept 18 who received external beam radiotherapy and were sent a questionnaire
|
41 |
| Percentage of men who responded |
76% |
|
|
No. of men who completed sufficient information for a validated EPIC-26 bowel function
score to be determined
|
29 |
|
Adjusted EPIC-26 bowel function score
(0=worst to 100=best)
|
80 |
|
|
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined
|
30 |
|
Adjusted EPIC-26 sexual function score
(0=worst to 100=best)
|
17 |
Compare provider outcomes
Copyright © 2021 National Prostate Cancer Audit | Lovingly Crafted by
Mixd